BLRX's logo.
Ticker Symbol: BLRX

Bioline Rx Ltd - ADR

$2.85 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: Israel Currency: USD Asset Type: ADR CIK:0001498403

Company Profile

biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'​in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Modi'in Technology Park
CEO: Philip Serlin
Tags:
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $1.36
Change: -$0.07 ( -4.90%)
Days Range: $1.35 - $1.45
Beta: 0.00
52wk. High: $2.52
52wk. Low: $0.54
Ytd. Change 125.61%
50 Day Moving Average: $1.83
200 Day Moving Average: $1.54
Shares Outstanding: 61530596

Valuation

Market Cap: 8.4B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A